Divided Vioxx jury told to keep trying

HOUSTON, Texas (AP) -- Jurors considering whether Vioxx contributed to a man's death told the judge Saturday they could not reach a unanimous verdict, but the judge told them to keep trying.
The nine-member federal jury has deliberated more than 12 hours over three days.
"It is your duty to agree on a verdict if you can do so without surrendering your own conscientious opinion," U.S. District Judge Eldon Fallon told jurors.
The judge told the panel that if they fail to reach a unanimous verdict, the case would be tried again, resulting in additional cost, time and effort by both sides.
He added that another jury wouldn't be any more qualified to consider the evidence.
The panel is considering whether the drug was defective, and whether New Jersey-based Merck & Co. failed to warn about its risks and was negligent in designing and marketing Vioxx.
If jurors answer yes, they then must decide whether any of those factors contributed to the 2001 fatal heart attack of Richard "Dicky" Irvin, 53, of St. Augustine, Florida, whose widow is suing Merck.
Merck pulled Vioxx from the market last year when a study showed the drug could double risk of heart attack or stroke if taken for 18 months or longer. Irvin died of a heart attack after taking Vioxx for about a month to ease back pain.
Merck claimed Vioxx couldn't be responsible for Irvin's death because he took Vioxx for such a short time. The plaintiff's lawyers said several studies among the 58 clinical trials involving 10,000 patients conducted before Vioxx was launched in 1999 showed dangers after only a few weeks' use.
If the jury finds Merck liable, the punitive damages will be determined in a later hearing in which attorneys can make arguments or call witnesses. Then the panel will deliberate and consider awarding punitive damages.